Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with prostate cancer confirmed by a biopsy showing a specific type called adenocarcinoma
- People for whom doctors have determined that an extended removal of lymph nodes in the pelvis, combined with robotic surgery to remove the prostate, is the recommended treatment (based on specific risk calculation tools used by the medical team)
- People who are considered medically suitable to undergo robotic prostate removal surgery with extended pelvic lymph node removal
- People who are mentally able to understand the potential benefits and demands of taking part in the study
- People who are willing and able to provide written consent to participate
- People with no known allergies to the PSMA tracer (a substance used in a special type of scan)
Who may not be able to join:
- People who have previously been diagnosed with or treated for prostate cancer
- People who have another cancer diagnosis at the same time (except a common, low-risk type of skin cancer called Basal Cell Carcinoma)
- People who are unwilling or unable to undergo the required PSMA PET/CT scan and/or the planned surgical procedures
- People whose prostate cancer does not show up on a PSMA scan in the area of the main tumour (confirm with trial site)
- People whose cancer has already spread to distant parts of the body
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jean-Paul A. van Basten, Canisius-Wilhelmina Hospital
Phone: 0681806668
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in biochemical recurrence rate between groups.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.